Susquehanna International Group
NBSE

Susquehanna International Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Susquehanna International Group’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-895
Closed -$50K – 14231
2021
Q4 		$50K Sell
895
-530
-37% -$35.6K ﹤0.01% 12546
2021
Q3 		$103K Buy
1,425
+400
+39% +$30.6K ﹤0.01% 12055
2021
Q2 		$98K Buy
+1,025
New +$113K ﹤0.01% 12107
2018
Q2 		– Sell
-27
Closed -$2K – 10623
2018
Q1 		$2K Buy
+27
New +$4.01K ﹤0.01% 9208
2017
Q1 		– Sell
-131
Closed -$78K – 10206
2016
Q4 		$78K Sell
131
-216
-62% -$228K ﹤0.01% 9175
2016
Q3 		$392K Sell
347
-27
-7% -$29.1K ﹤0.01% 6498
2016
Q2 		$410K Sell
374
-63
-14% -$79.1K ﹤0.01% 6461
2016
Q1 		$561K Buy
437
+56
+15% +$79.8K ﹤0.01% 6205
2015
Q4 		$935K Sell
381
-154
-29% -$236K ﹤0.01% 5543
2015
Q3 		$590K Buy
535
+293
+121% +$339K ﹤0.01% 6803
2015
Q2 		$243K Buy
242
+70
+41% +$75.5K ﹤0.01% 8942
2015
Q1 		$174K Buy
+172
New +$568K ﹤0.01% 8724
2014
Q4 		– Sell
-82
Closed -$238K – 10206
2014
Q3 		$238K Sell
82
-64
-44% -$212K ﹤0.01% 8384
2014
Q2 		$556K Buy
+146
New +$550K ﹤0.01% 7265

Other funds holding NBSE

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
CMU
Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group's NBSE Position: Q2 2023 in Review

Susquehanna International Group sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2023, closing a stake of 963 shares — an estimated $3.56K sold.

Susquehanna International Group first reported a position in NBSE in Q3 2013 and held it in 23 quarters. The position peaked at $759K in Q1 2014. 27 funds tracked by Wall St. Rank hold NBSE as of Q2 2023.

  • Susquehanna International Group reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 963 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $3.56K.
  • Susquehanna International Group first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q3 2013 and held it in 23 quarters.
  • Susquehanna International Group's NeuBase Therapeutics, Inc. Common Stock position peaked at $759K in Q1 2014.
  • 27 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.